Long-Term Dietary Supplementation with Selenium-Enriched Yeast Improves Cognitive Impairment, Reverses Synaptic Deficits, and Mitigates Tau Pathology in a Triple Transgenic Mouse Model of Alzheimer's Disease

Journal of Agricultural and Food Chemistry

Volumn 65, Issue 24, 2017, Pages 4970-4979

  Zhang, Zhong Hao ^a   Wen, Lei ^a   Wu, Qiu Yan ^a   Chen, Chen ^a   Zheng, Rui ^a   Liu, Qiong ^a   Ni, Jia Zuan ^a   Song, Guo Li ^a  

^a SHENZHEN UNIVERSITY   (China)

Author keywords

Alzheimer's disease; cognitive impairment; hyperphosphorylated tau; inflammatory response; magnetic resonance spectroscopy

Indexed keywords

DIETARY SUPPLEMENTS; MAGNETIC RESONANCE; MAGNETIC RESONANCE SPECTROSCOPY; MAMMALS; NUTRITION; SELENIUM; YEAST;

ALZHEIMER'S DISEASE; COGNITIVE FUNCTIONS; COGNITIVE IMPAIRMENT; DIETARY SUPPLEMENTATION; HYPERPHOSPHORYLATED; INFLAMMATORY RESPONSE; NEURODEGENERATIVE DISORDERS; NEURONAL ACTIVITIES;

NEURODEGENERATIVE DISEASES;

NEUROPROTECTIVE AGENT; SELENIUM; TAU PROTEIN;

ALZHEIMER DISEASE; ANALYSIS; ANIMAL; CHEMISTRY; DIETARY SUPPLEMENT; DISEASE COURSE; DISEASE MODEL; DRUG EFFECTS; GENETICS; HIPPOCAMPUS; HUMAN; MALE; MEMORY; METABOLISM; MOUSE; PHOSPHORYLATION; PSYCHOLOGY; SACCHAROMYCES CEREVISIAE; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HIPPOCAMPUS; HUMANS; MALE; MEMORY; MICE; MICE, TRANSGENIC; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION; SACCHAROMYCES CEREVISIAE; SELENIUM; TAU PROTEINS;

EID: 85021151630     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/acs.jafc.7b01465     Document Type: Article

References (62)

1. Giannopoulos, P. F.; Chu, J.; Joshi, Y. B.; Sperow, M.; Li, J. G.; Kirby, L. G.; Pratico, D. 5-lipoxygenase activating protein reduction ameliorates cognitive deficit, synaptic dysfunction, and neuropathology in a mouse model of Alzheimer's disease Biol. Psychiatry 2013, 74, 348-356 10.1016/j.biopsych.2013.04.009
2. Peng, Y.; Sun, J.; Hon, S.; Nylander, A. N.; Xia, W.; Feng, Y.; Wang, X.; Lemere, C. A. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease J. Neurosci. 2010, 30, 8180-8189 10.1523/JNEUROSCI.0340-10.2010
3. Shelton, S. B.; Johnson, G. V. Tau and HMW tau phosphorylation and compartmentalization in apoptotic neuronal PC12 cells J. Neurosci. Res. 2001, 66, 203-213 10.1002/jnr.1212
4. Goedert, M.; Jakes, R.; Spillantini, M. G.; Hasegawa, M.; Smith, M. J.; Crowther, R. A. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans Nature 1996, 383, 550-553 10.1038/383550a0
5. Chen, F.; David, D.; Ferrari, A.; Gotz, J. Posttranslational modifications of tau - role in human tauopathies and modeling in transgenic animals Curr. Drug Targets 2004, 5, 503-515 10.2174/1389450043345236
6. Buee, L.; Delacourte, A. Tauopathy and Alzheimer disease: A full degenerating process (in French) Psychol. Neuropsychiatr. Vieil. 2006, 4, 261-273
7. Martin, L.; Latypova, X.; Terro, F. Post-translational modifications of tau protein: implications for Alzheimer's disease Neurochem. Int. 2011, 58, 458-471 10.1016/j.neuint.2010.12.023
8. Elyaman, W.; Terro, F.; Wong, N. S.; Hugon, J. In vivo activation and nuclear translocation of phosphorylated glycogen synthase kinase-3beta in neuronal apoptosis: links to tau phosphorylation European journal of neuroscience 2002, 15, 651-660 10.1046/j.1460-9568.2002.01899.x
9. Terwel, D.; Muyllaert, D.; Dewachter, I.; Borghgraef, P.; Croes, S.; Devijver, H.; Van Leuven, F. Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice Am. J. Pathol. 2008, 172, 786-798 10.2353/ajpath.2008.070904
10. Gao, X.; Joselin, A. P.; Wang, L.; Kar, A.; Ray, P.; Bateman, A.; Goate, A. M.; Wu, J. Y. Progranulin promotes neurite outgrowth and neuronal differentiation by regulating GSK-3beta Protein Cell 2010, 1, 552-562 10.1007/s13238-010-0067-1
11. Sontag, J. M.; Wasek, B.; Taleski, G.; Smith, J.; Arning, E.; Sontag, E.; Bottiglieri, T. Altered protein phosphatase 2A methylation and Tau phosphorylation in the young and aged brain of methylenetetrahydrofolate reductase (MTHFR) deficient mice Front. Aging Neurosci. 2014, 6, 214 10.3389/fnagi.2014.00214
12. Liu, F.; Grundke-Iqbal, I.; Iqbal, K.; Gong, C. X. Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation European journal of neuroscience 2005, 22, 1942-1950 10.1111/j.1460-9568.2005.04391.x
13. Gao, S.; Jin, Y.; Hall, K. S.; Liang, C.; Unverzagt, F. W.; Ji, R.; Murrell, J. R.; Cao, J.; Shen, J.; Ma, F.; Matesan, J.; Ying, B.; Cheng, Y.; Bian, J.; Li, P.; Hendrie, H. C. Selenium level and cognitive function in rural elderly Chinese Am. J. Epidemiol. 2007, 165, 955-965 10.1093/aje/kwk073
14. Akbaraly, T. N.; Hininger-Favier, I.; Carriere, I.; Arnaud, J.; Gourlet, V.; Roussel, A. M.; Berr, C. Plasma selenium over time and cognitive decline in the elderly Epidemiology (Cambridge, Mass.) 2007, 18, 52-58 10.1097/01.ede.0000248202.83695.4e
15. Ishrat, T.; Parveen, K.; Khan, M. M.; Khuwaja, G.; Khan, M. B.; Yousuf, S.; Ahmad, A.; Shrivastav, P.; Islam, F. Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type Brain Res. 2009, 1281, 117-127 10.1016/j.brainres.2009.04.010
16. Ellwanger, J. H.; Molz, P.; Dallemole, D. R.; Pereira dos Santos, A.; Muller, T. E.; Cappelletti, L.; Goncalves da Silva, M.; Rech Franke, S. I.; Pra, D.; Pegas Henriques, J. A. Selenium reduces bradykinesia and DNA damage in a rat model of Parkinson's disease Nutrition 2015, 31, 359-365 10.1016/j.nut.2014.07.004
17. Alfthan, G.; Aro, A.; Arvilommi, H.; Huttunen, J. K. Selenium metabolism and platelet glutathione peroxidase activity in healthy Finnish men: Effects of selenium yeast, selenite, and selenate Am. J. Clin. Nutr. 1991, 53, 120-125
18. Loscalzo, J. Keshan disease, selenium deficiency, and the selenoproteome N. Engl. J. Med. 2014, 370, 1756-1760 10.1056/NEJMcibr1402199
19. Wang, L.; Wang, J.; Liu, X.; Liu, Q.; Zhang, G.; Liang, L. Association between selenium intake and the risk of pancreatic cancer: a meta-analysis of observational studies Biosci. Rep. 2016, 36, e00395 10.1042/BSR20160345
20. Baowei, W.; Guoqing, H.; Qiaoli, W.; Bin, Y. Effects of yeast selenium supplementation on the growth performance, meat quality, immunity, and antioxidant capacity of goose J. Anim. Physiol. Anim. Nutr. 2011, 95, 440-448 10.1111/j.1439-0396.2010.01070.x
21. Song, G.; Zhang, Z.; Wen, L.; Chen, C.; Shi, Q.; Zhang, Y.; Ni, J.; Liu, Q. Selenomethionine ameliorates cognitive decline, reduces tau hyperphosphorylation, and reverses synaptic deficit in the triple transgenic mouse model of Alzheimer's disease J. Alzheimers Dis 2014, 41, 85-99 10.3233/JAD-131805
22. Zhang, Z. H.; Chen, C.; Wu, Q. Y.; Zheng, R.; Liu, Q.; Ni, J. Z.; Hoffmann, P. R.; Song, G. L. Selenomethionine reduces the deposition of beta-amyloid plaques by modulating beta-secretase and enhancing selenoenzymatic activity in a mouse model of Alzheimer's disease Metallomics 2016, 8, 782-789 10.1039/C6MT00117C
23. Oddo, S.; Caccamo, A.; Kitazawa, M.; Tseng, B. P.; LaFerla, F. M. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease Neurobiol. Aging 2003, 24, 1063-1070 10.1016/j.neurobiolaging.2003.08.012
24. Morris, R. G.; Garrud, P.; Rawlins, J. N.; O'Keefe, J. Place navigation impaired in rats with hippocampal lesions Nature 1982, 297, 681-683 10.1038/297681a0
25. Kim, S. R.; Hwang, S. Y.; Jang, Y. P.; Park, M. J.; Markelonis, G. J.; Oh, T. H.; Kim, Y. C. Protopine from Corydalis ternata has anticholinesterase and antiamnesic activities Planta Med. 1999, 65, 218-221 10.1055/s-1999-13983
26. Hiramatsu, M.; Sasaki, M.; Nabeshima, T.; Kameyama, T. Effects of dynorphin A (1-13) on carbon monoxide-induced delayed amnesia in mice Pharmacol., Biochem. Behav. 1997, 56, 73-79 10.1016/S0091-3057(96)00159-1
27. Calsolaro, V.; Edison, P. Neuroinflammation in Alzheimer's disease: Current evidence and future directions Alzheimer's Dementia 2016, 12, 719-732 10.1016/j.jalz.2016.02.010
28. Terwel, D.; Lasrado, R.; Snauwaert, J.; Vandeweert, E.; Van Haesendonck, C.; Borghgraef, P.; Van Leuven, F. Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice J. Biol. Chem. 2005, 280, 3963-3973 10.1074/jbc.M409876200
29. Newman, K. P.; Neal, M. T.; Roberts, M.; Goodwin, K. D.; Hatcher, E. A.; Bhattacharya, S. K. The importance of lost minerals in heart failure Cardiovasc. Hematol. Agents Med. Chem. 2007, 5, 295-299 10.2174/187152507782109872
30. Yang, Z.; Liu, C.; Liu, C.; Teng, X.; Li, S. Selenium Deficiency Mainly Influences Antioxidant Selenoproteins Expression in Broiler Immune Organs Biol. Trace Elem. Res. 2016, 172, 209-221 10.1007/s12011-015-0578-y
31. Corcoran, N. M.; Martin, D.; Hutter-Paier, B.; Windisch, M.; Nguyen, T.; Nheu, L.; Sundstrom, L. E.; Costello, A. J.; Hovens, C. M. Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model J. Clin. Neurosci. 2010, 17, 1025-1033 10.1016/j.jocn.2010.04.020
32. Zeng, H.; Jackson, M. I.; Cheng, W. H.; Combs, G. F., Jr. Chemical form of selenium affects its uptake, transport, and glutathione peroxidase activity in the human intestinal Caco-2 cell model Biol. Trace Elem. Res. 2011, 143, 1209-1218 10.1007/s12011-010-8935-3
33. Schrauzer, G. N. The nutritional significance, metabolism and toxicology of selenomethionine Adv. Food Nutr. Res. 2003, 47, 73-112 10.1016/S1043-4526(03)47002-2
34. Xia, Y.; Hill, K. E.; Byrne, D. W.; Xu, J.; Burk, R. F. Effectiveness of selenium supplements in a low-selenium area of China Amer. J. Clin. Nutr. 2005, 81, 829-834
35. Xiong, S.; Markesbery, W. R.; Shao, C.; Lovell, M. A. Seleno-L-methionine protects against beta-amyloid and iron/hydrogen peroxide-mediated neuron death Antioxid. Redox Signaling 2007, 9, 457-467 10.1089/ars.2006.1363
36. Zhang, Z. H.; Wu, Q. Y.; Zheng, R.; Chen, C.; Chen, Y.; Liu, Q.; Hoffmann, P. R.; Ni, J. Z.; Song, G. L. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model J. Neurosci. 2017, 37, 2449-2462 10.1523/JNEUROSCI.3229-16.2017
37. Opienska-Blauth, J.; Dobrowolski, J.; Grzebula, S.; Bartosz, G. Selenium in biology and medicine (in Polish) Postepy Hig. Med. Dosw. 1981, 34, 491-524
38. Lovell, M. A.; Xiong, S.; Lyubartseva, G.; Markesbery, W. R. Organoselenium (Sel-Plex diet) decreases amyloid burden and RNA and DNA oxidative damage in APP/PS1 mice Free Radical Biol. Med. 2009, 46, 1527-1533 10.1016/j.freeradbiomed.2009.03.008
39. Berr, C.; Arnaud, J.; Akbaraly, T. N. Selenium and cognitive impairment: a brief-review based on results from the EVA study BioFactors (Oxford, England) 2012, 38, 139-144 10.1002/biof.1003
40. Butterfield, D. A. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review Free Radical Res. 2002, 36, 1307-1313 10.1080/1071576021000049890
41. Ma, Q.; Ruan, Y. Y.; Xu, H.; Shi, X. M.; Wang, Z. X.; Hu, Y. L. Safflower yellow reduces lipid peroxidation, neuropathology, tau phosphorylation and ameliorates amyloid beta-induced impairment of learning and memory in rats Biomed. Pharmacother. 2015, 76, 153-164 10.1016/j.biopha.2015.10.004
42. Mosconi, L.; Sorbi, S.; de Leon, M. J.; Li, Y.; Nacmias, B.; Myoung, P. S.; Tsui, W.; Ginestroni, A.; Bessi, V.; Fayyazz, M.; Caffarra, P.; Pupi, A. Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease J. Nucl. Med. 2006, 47, 1778-1786
43. Chen, Y. J.; Zheng, H. Y.; Huang, X. X.; Han, S. X.; Zhang, D. S.; Ni, J. Z.; He, X. Y. Neuroprotective Effects of Icariin on Brain Metabolism, Mitochondrial Functions, and Cognition in Triple-Transgenic Alzheimer's Disease Mice CNS Neurosci. Ther. 2016, 22, 63-73 10.1111/cns.12473
44. Wang, Z.; Zhao, C.; Yu, L.; Zhou, W.; Li, K. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-T magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease Acta Radiol. 2009, 50, 312-319 10.1080/02841850802709219
45. Huang, W.; Alexander, G. E.; Chang, L.; Shetty, H. U.; Krasuski, J. S.; Rapoport, S. I.; Schapiro, M. B. Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study Neurology 2001, 57, 626-632 10.1212/WNL.57.4.626
46. Block, W.; Jessen, F.; Traber, F.; Flacke, S.; Manka, C.; Lamerichs, R.; Keller, E.; Heun, R.; Schild, H. Regional N-acetylaspartate reduction in the hippocampus detected with fast proton magnetic resonance spectroscopic imaging in patients with Alzheimer disease Arch. Neurol. 2002, 59, 828-834 10.1001/archneur.59.5.828
47. Salek, R. M.; Xia, J.; Innes, A.; Sweatman, B. C.; Adalbert, R.; Randle, S.; McGowan, E.; Emson, P. C.; Griffin, J. L. A metabolomic study of the CRND8 transgenic mouse model of Alzheimer's disease Neurochem. Int. 2010, 56, 937-947 10.1016/j.neuint.2010.04.001
48. Harris, R. A.; Tindale, L.; Lone, A.; Singh, O.; Macauley, S. L.; Stanley, M.; Holtzman, D. M.; Bartha, R.; Cumming, R. C. Aerobic Glycolysis in the Frontal Cortex Correlates with Memory Performance in Wild-Type Mice But Not the APP/PS1Mouse Model of Cerebral Amyloidosis J. Neurosci. 2016, 36, 1871-1878 10.1523/JNEUROSCI.3131-15.2016
49. Yang, D.; Xie, Z.; Stephenson, D.; Morton, D.; Hicks, C. D.; Brown, T. M.; Sriram, R.; O'Neill, S.; Raunig, D.; Bocan, T. Volumetric MRI and MRS provide sensitive measures of Alzheimer's disease neuropathology in inducible Tau transgenic mice (rTg4510) NeuroImage 2011, 54, 2652-2658 10.1016/j.neuroimage.2010.10.067
50. Woo, D. C.; Lee, S. H.; Lee, D. W.; Kim, S. Y.; Kim, G. Y.; Rhim, H. S.; Choi, C. B.; Kim, H. Y.; Lee, C. U.; Choe, B. Y. Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS Behav. Brain Res. 2010, 211, 125-131 10.1016/j.bbr.2010.03.026
51. Morris, M.; Maeda, S.; Vossel, K.; Mucke, L. The many faces of tau Neuron 2011, 70, 410-426 10.1016/j.neuron.2011.04.009
52. Roberson, E. D.; Scearce-Levie, K.; Palop, J. J.; Yan, F.; Cheng, I. H.; Wu, T.; Gerstein, H.; Yu, G. Q.; Mucke, L. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model Science 2007, 316, 750-754 10.1126/science.1141736
53. Lucas, J. J.; Hernandez, F.; Gomez-Ramos, P.; Moran, M. A.; Hen, R.; Avila, J. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice EMBO J. 2001, 20, 27-39 10.1093/emboj/20.1.27
54. Qu, Z. S.; Li, L.; Sun, X. J.; Zhao, Y. W.; Zhang, J.; Geng, Z.; Fu, J. L.; Ren, Q. G. Glycogen synthase kinase-3 regulates production of amyloid-beta peptides and tau phosphorylation in diabetic rat brain Sci. World J. 2014, 2014, 878123 10.1155/2014/878123
55. Wang, J. Z.; Wu, Q.; Smith, A.; Grundke-Iqbal, I.; Iqbal, K. Tau is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase FEBS Lett. 1998, 436, 28-34 10.1016/S0014-5793(98)01090-4
56. Arif, M.; Wei, J.; Zhang, Q.; Liu, F.; Basurto-Islas, G.; Grundke-Iqbal, I.; Iqbal, K. Cytoplasmic retention of protein phosphatase 2A inhibitor 2 (I2PP2A) induces Alzheimer-like abnormal hyperphosphorylation of Tau J. Biol. Chem. 2014, 289, 27677-27691 10.1074/jbc.M114.565358
57. Uttara, B.; Singh, A. V.; Zamboni, P.; Mahajan, R. T. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options Curr. Neuropharmacol 2009, 7, 65-74 10.2174/157015909787602823
58. Pratico, D.; Clark, C. M.; Liun, F.; Lee, V. Y.; Trojanowski, J. Q. Increase of brain oxidative stress in mild cognitive impairment: A possible predictor of Alzheimer disease Arch. Neurol. 2002, 59, 972-976 10.1001/archneur.59.6.972
59. Heneka, M. T.; Rodriguez, J. J.; Verkhratsky, A. Neuroglia in neurodegeneration Brain Res. Rev. 2010, 63, 189-211 10.1016/j.brainresrev.2009.11.004
60. Nakajima, K.; Kohsaka, S. Microglia: activation and their significance in the central nervous system J. Biochem. 2001, 130, 169-175 10.1093/oxfordjournals.jbchem.a002969
61. Manczak, M.; Anekonda, T. S.; Henson, E.; Park, B. S.; Quinn, J.; Reddy, P. H. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: Implications for free radical generation and oxidative damage in disease progression Hum. Mol. Genet. 2006, 15, 1437-1449 10.1093/hmg/ddl066
62. Gibson, G. E.; Karuppagounder, S. S.; Shi, Q. Oxidant-induced changes in mitochondria and calcium dynamics in the pathophysiology of Alzheimer's disease Ann. N. Y. Acad. Sci. 2008, 1147, 221-232 10.1196/annals.1427.038